RiverVest Venture Partners related stories
All articles and analysis
ZS Pharma Nets $46M for Kidney, Liver DiseaseSpecialty pharmaceutical company ZS Pharma Inc. closed a $46 million financing round to support development of its treatments for kidney and liver disease. Alta Partners led the new round of financing, joined by new investors RiverVest Venture Partners, 3x5 Special Opportunity Partners and Salem Partners as well as current investor Devon Park Bioventures. The company is based in Fort Worth, Texas.
- Pfizer Buys Excaliard Pharmaceuticals
Pfizer Inc. is buying Excaliard Pharmaceuticals Inc. for an undisclosed amount. Excaliard develops drugs for the treatment of skin fibrosis. Excaliard Pharmaceuticals previously raised venture financing from Alta Partners, ProQuest Investments and RiverVest Venture Partners.
- JumpStart and RiverVest Back Securus Medical
Securus Medical Group has scored $750,000 from RiverVest Venture Partners and from Ohio-based non-profit investor JumpStart. Securus Medical is developing a product that provides real-time temperature mapping within a hollow body cavity, the company said in a written release. Securus is based in Cleveland.
- VC People Moves, June 2011
Hires and other personnel changes at Greycroft, Lightbank and Chrysalis among other VC firms